The New York State Department of Health (NYSDOH) has implemented a program that allows the pharmacy community to submit MEVS transactions in an on-line real-time environment that performs a Prospective Drug Utilization Review (Pro-DUR). This program was implemented on June 1, 1994 and is being administered by the fiscal agent. In order to receive payment for services rendered, all pharmacies must submit their transactions through the on-line DUR program. If desired, this program can also capture claims electronically and transmit them to the fiscal agent for adjudication. The purpose of the Pro-DUR program is to comply with OBRA 90 mandated Pro-DUR requirements. This program will check all prescriptions with prescription drugs the recipient has taken over the past 90 days and alerts the pharmacists to possible medical problems associated with dispensing the new drug.
This manual is designed to familiarize you with the ProDUR/ECCA system, and contains multiple sections discussing the different aspects of the ProDUR system. You may either view or download this manual by using the options below.
ProDUR/ECCA Provider Manual D.0 - Version 2.61: April 13, 2023 |
||
ProDUR/ECCA D.0 Provider Manual Archive |
Retired versions of the ProDUR/ECCA Provider manual can be found in the ProDUR/ECCA Provider Manual Archive.
Retired versions of the ProDUR/ECCA Standards manual can be found in the ProDUR/ECCA Standards Manual Archive.